Machelle T Pardue Selected Research

Myopia

1/2022	Melanopsin modulates refractive development and myopia.
1/2021	Ambient Light Regulates Retinal Dopamine Signaling and Myopia Susceptibility.
1/2021	IMI 2021 Yearly Digest.
1/2020	Short-Wavelength (Violet) Light Protects Mice From Myopia Through Cone Signaling.
1/2020	Assessment of Visual and Retinal Function Following In Vivo Genipin-Induced Scleral Crosslinking.
1/2019	Lack of cone mediated retinal function increases susceptibility to form-deprivation myopia in mice.
1/2019	Altered ocular parameters from circadian clock gene disruptions.
1/2018	Circadian rhythms, refractive development, and myopia.
11/2017	Dopamine signaling and myopia development: What are the key challenges.
11/2016	Genome-Wide Scleral Micro- and Messenger-RNA Regulation During Myopia Development in the Mouse.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Machelle T Pardue Research Topics

Disease

20	Myopia 01/2022 - 03/2007
17	Retinal Degeneration 01/2022 - 12/2006
6	Refractive Errors (Refractive Error) 01/2022 - 01/2013
6	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2021 - 11/2008
6	Retinal Diseases 01/2019 - 01/2011
6	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2019 - 05/2002
5	Glaucoma 01/2022 - 01/2020
5	Hyperglycemia 07/2021 - 02/2013
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2021 - 02/2013
4	Ganglion Cysts (Ganglion) 11/2014 - 04/2006
3	Ocular Hypertension (Glaucoma, Suspect) 01/2022 - 01/2020
3	Ischemia 01/2021 - 04/2014
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2016 - 04/2014
2	Cognitive Dysfunction 01/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 11/2016
1	Obesity 01/2021
1	Gliosis 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Disease Progression 01/2020
1	Infections 01/2020
1	Glucose Intolerance 01/2019
1	Amblyopia (Lazy Eye) 01/2018
1	Brain Diseases (Brain Disorder) 01/2018
1	Optic Nerve Injuries 01/2018
1	Myopia 1 11/2017
1	Intellectual Disability (Idiocy) 10/2017
1	Infarction (Infarctions) 05/2015
1	Spinal Cord Injuries (Spinal Cord Injury) 05/2015
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 05/2015
1	Stroke (Strokes) 05/2015
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2015
1	Cicatrix (Scar) 11/2014
1	Brain Ischemia (Cerebral Ischemia) 04/2014
1	Cerebral Infarction 04/2014
1	Nervous System Diseases (Neurological Disorders) 01/2014
1	Parkinson Disease (Parkinson's Disease) 01/2014
1	Cataract (Cataracts) 02/2013
1	Hyperopia (Hypermetropia) 01/2013
1	AIDS-Related Complex (ARC) 07/2011
1	Hyperoxia 01/2011
1	Hypercapnia 01/2011
1	Muscular Diseases (Myopathy) 12/2010

Drug/Important Bio-Agent (IBA)

43	Retinaldehyde (Retinal)IBA 01/2022 - 05/2002
10	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2013
4	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022 - 01/2014
4	Neuroprotective AgentsIBA 01/2022 - 03/2005
4	ursodoxicoltaurineIBA 07/2021 - 12/2006
3	3,4-Dihydroxyphenylacetic AcidIBA 01/2022 - 01/2013
3	Levodopa (L Dopa)FDA LinkGeneric 01/2022 - 01/2020
3	NeurosteroidsIBA 01/2018 - 05/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 02/2014
2	melanopsinIBA 01/2022 - 09/2013
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2017
2	Atropine FDA LinkGeneric 01/2021 - 09/2013
2	Progesterone FDA LinkGeneric 11/2016 - 05/2015
1	Latanoprost (Xalatan)FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Anesthetics (Anesthetic Agents)IBA 01/2021
1	Isoflurane FDA LinkGeneric 01/2021
1	LipidsIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Pyridinolcarbamate (P23)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 11/2020
1	genipinIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	Rhodopsin (Visual Purple)IBA 01/2019
1	Pregnanolone (Allopregnanolone)IBA 01/2018
1	Biological ProductsIBA 11/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2017
1	polyadenosineIBA 10/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2016
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 08/2016
1	Phosphotransferases (Kinase)IBA 10/2015
1	TropomyosinIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2015
1	Fluorescent Dyes (Fluorescent Probes)IBA 09/2015
1	TransducinIBA 09/2014
1	Streptozocin (Streptozotocin)FDA Link 05/2014
1	Glutamic Acid (Glutamate)FDA Link 04/2014
1	TESIBA 01/2014
1	Pharmaceutical PreparationsIBA 09/2013
1	Melatonin Receptors (Melatonin Receptor)IBA 09/2013
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 09/2013
1	manganese chloride (manganese chloride, tetrahydrate)FDA Link 12/2011
1	Complement System Proteins (Complement)IBA 01/2011
1	Adenosine Triphosphate (ATP)IBA 12/2010
1	SiliconIBA 12/2010

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2018
2	Electric Stimulation Therapy (Electrotherapy) 01/2016 - 01/2014
1	Microspheres (Microsphere) 01/2022
1	Preoperative Exercise 01/2021
1	Eyeglasses (Spectacles) 01/2021
1	Suture Techniques 04/2014
1	Slit Lamp 02/2013